Journal Article
. 2008 Oct;20(2).
doi: 10.1093/annonc/mdn590.

Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial

M Schmidt 1 A Victor  D Bratzel  D Boehm  C Cotarelo  A Lebrecht  W Siggelkow  J G Hengstler  A Elsässer  M Gehrmann  H-A Lehr  H Koelbl  G von Minckwitz  N Harbeck  C Thomssen  
Affiliations
  • PMID: 18824499
  •     35 citations

Abstract

Background: Defining risk categories in breast cancer is of considerable clinical significance. We have developed a novel risk classification algorithm and compared its prognostic utility to the Web-based tool Adjuvant! and to the St Gallen risk classification.

Patients And Methods: After a median follow-up of 10 years, we retrospectively analyzed 410 consecutive node-negative breast cancer patients who had not received adjuvant systemic therapy. High risk was defined by any of the following criteria: (i) age <35 years, (ii) grade 3, (iii) human epithelial growth factor receptor-2 positivity, (iv) vascular invasion, (v) progesterone receptor negativity, (vi) grade 2 tumors >2 cm. All patients were also characterized using Adjuvant! and the St Gallen 2007 risk categories. We analyzed disease-free survival (DFS) and overall survival (OS).

Results: The Node-Negative-Breast Cancer-3 (NNBC-3) algorithm enlarged the low-risk group to 37% as compared with Adjuvant! (17%) and St Gallen (18%), respectively. In multivariate analysis, both Adjuvant! [P = 0.027, hazard ratio (HR) 3.81, 96% confidence interval (CI) 1.16-12.47] and the NNBC-3 risk classification (P = 0.049, HR 1.95, 95% CI 1.00-3.81) significantly predicted OS, but only the NNBC-3 algorithm retained its prognostic significance in multivariate analysis for DFS (P < 0.0005).

Conclusion: The novel NNBC-3 risk algorithm is the only clinicopathological risk classification algorithm significantly predicting DFS as well as OS.

An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.
H E Campbell, M A Taylor, A L Harris, A M Gray.
Br J Cancer, 2009 Sep 03; 101(7). PMID: 19724274    Free PMC article.
Obesity and angiolymphatic invasion in primary breast cancer.
Erin F Gillespie, Melony E Sorbero, +5 authors, Jennifer J Griggs.
Ann Surg Oncol, 2009 Nov 10; 17(3). PMID: 19898898    Free PMC article.
Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer.
Katrina Bauer, Carol Parise, Vincent Caggiano.
BMC Cancer, 2010 May 25; 10. PMID: 20492696    Free PMC article.
Comparison of scores for bimodality of gene expression distributions and genome-wide evaluation of the prognostic relevance of high-scoring genes.
Birte Hellwig, Jan G Hengstler, +3 authors, Jörg Rahnenführer.
BMC Bioinformatics, 2010 May 27; 11. PMID: 20500820    Free PMC article.
Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer.
Cristina Cadenas, Dennis Franckenstein, +14 authors, Jan G Hengstler.
Breast Cancer Res, 2010 Jun 30; 12(3). PMID: 20584310    Free PMC article.
Node-Negative Breast Cancer: Which Patients Should Be Treated?
Marcus Schmidt.
Breast Care (Basel), 2008 Jan 01; 3(4). PMID: 21076603    Free PMC article.
Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction.
Pierre-Emmanuel Colombo, Fernanda Milanezi, Britta Weigelt, Jorge S Reis-Filho.
Breast Cancer Res, 2011 Jul 27; 13(3). PMID: 21787441    Free PMC article.
Review.
External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement.
David Hajage, Yann de Rycke, +11 authors, Fabien Reyal.
PLoS One, 2011 Nov 17; 6(11). PMID: 22087319    Free PMC article.
Accuracy validation of adjuvant! online in Taiwanese breast cancer patients--a 10-year analysis.
Kuo Yao-Lung, Chen Dar-Ren, Chang Tsai-Wang.
BMC Med Inform Decis Mak, 2012 Sep 19; 12. PMID: 22985190    Free PMC article.
Immunoglobulin kappa C predicts overall survival in node-negative breast cancer.
Zonglin Chen, Aslihan Gerhold-Ay, +13 authors, Marcus Schmidt.
PLoS One, 2012 Oct 03; 7(9). PMID: 23028600    Free PMC article.
Immunoglobulin kappa chain as an immunologic biomarker of prognosis and chemotherapy response in solid tumors.
Marcus Schmidt, Patrick Micke, Mathias Gehrmann, Jan G Hengstler.
Oncoimmunology, 2012 Nov 22; 1(7). PMID: 23170262    Free PMC article.
Prediction of breast cancer metastasis by gene expression profiles: a comparison of metagenes and single genes.
Mark Burton, Mads Thomassen, Qihua Tan, Torben A Kruse.
Cancer Inform, 2013 Jan 11; 11. PMID: 23304070    Free PMC article.
Ceramide kinase promotes tumor cell survival and mammary tumor recurrence.
Ania W Payne, Dhruv K Pant, Tien-Chi Pan, Lewis A Chodosh.
Cancer Res, 2014 Aug 29; 74(21). PMID: 25164007    Free PMC article.
Chemotherapy in early breast cancer: when, how and which one?
Marcus Schmidt.
Breast Care (Basel), 2014 Sep 02; 9(3). PMID: 25177256    Free PMC article.
Review.
Individualizing life expectancy estimates for older adults using the Gompertz Law of Human Mortality.
Sei J Lee, W John Boscardin, Katharine A Kirby, Kenneth E Covinsky.
PLoS One, 2014 Sep 30; 9(9). PMID: 25265291    Free PMC article.
Prognostic influence of pre-operative C-reactive protein in node-negative breast cancer patients.
Isabel Sicking, Karolina Edlund, +10 authors, Marcus Schmidt.
PLoS One, 2014 Oct 24; 9(10). PMID: 25340395    Free PMC article.
Post-operative nomogram for predicting freedom from recurrence after surgery in localised breast cancer receiving adjuvant hormone therapy.
Chafika Mazouni, Frédéric Fina, +3 authors, Pierre-Marie Martin.
J Cancer Res Clin Oncol, 2014 Dec 01; 141(6). PMID: 25433507
Loss of circadian clock gene expression is associated with tumor progression in breast cancer.
Cristina Cadenas, Leonie van de Sandt, +7 authors, Jan G Hengstler.
Cell Cycle, 2014 Dec 09; 13(20). PMID: 25485508    Free PMC article.
Highly Cited.
The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma.
Rocío Montes de Oca, Zachary A Gurard-Levin, +12 authors, Geneviève Almouzni.
Mol Oncol, 2014 Dec 17; 9(3). PMID: 25497280    Free PMC article.
Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.
Isabel Sicking, Karlien Rommens, +7 authors, Marcus Schmidt.
BMC Cancer, 2014 Dec 17; 14. PMID: 25511800    Free PMC article.
Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based models.
E Laas, P Mallon, +7 authors, F Reyal.
Br J Cancer, 2015 Jan 16; 112(5). PMID: 25590666    Free PMC article.
Long non-coding RNA expression profiles predict metastasis in lymph node-negative breast cancer independently of traditional prognostic markers.
Kristina P Sørensen, Mads Thomassen, +5 authors, Torben A Kruse.
Breast Cancer Res, 2015 Apr 19; 17. PMID: 25887545    Free PMC article.
Cancer research: from prognostic genes to therapeutic targets.
Rosemarie Marchan.
EXCLI J, 2014 Jan 01; 13. PMID: 26417341    Free PMC article.
The Performance of the Nottingham Prognosis Index and the Adjuvant Online Decision Making Tool for Prognosis in Early-stage Breast Cancer Patients.
Mehri Rejali, Mehdi Tazhibi, +2 authors, Reyhane Mokarian.
Int J Prev Med, 2015 Nov 26; 6. PMID: 26605014    Free PMC article.
Biomarkers in Breast Cancer - An Update.
M Schmidt, P A Fasching, M W Beckmann, H Kölbl.
Geburtshilfe Frauenheilkd, 2012 Sep 01; 72(9). PMID: 26640290    Free PMC article.
High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancers.
William Jacot, Caroline Mollevi, +6 authors, Pierre-Jean Lamy.
BMC Cancer, 2015 Dec 19; 15. PMID: 26680641    Free PMC article.
Prognostic signatures of breast cancer: Perou's molecular subtypes and Schmidt's metagenes.
Cristina Cadenas.
EXCLI J, 2012 Jan 01; 11. PMID: 27231466    Free PMC article.
Lung and breast cancer research: immunoglobulin Kappa C hits the headlines.
Rosemarie Marchan.
EXCLI J, 2012 Jan 01; 11. PMID: 27231467    Free PMC article.
Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.
Vida Pourteimoor, Samira Mohammadi-Yeganeh, Mahdi Paryan.
Tumour Biol, 2016 Sep 22; 37(11). PMID: 27651157
Review.
Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer.
Amro Masarwah, Päivi Auvinen, +6 authors, Ritva Vanninen.
BMC Cancer, 2016 Nov 04; 16(1). PMID: 27806715    Free PMC article.
Targeting Intracellular Calcium Signaling ([Ca2+]i) to Overcome Acquired Multidrug Resistance of Cancer Cells: A Mini-Overview.
Dietrich Büsselberg, Ana-Maria Florea.
Cancers (Basel), 2017 May 10; 9(5). PMID: 28486397    Free PMC article.
Review.
Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction.
Molly Scannell Bryan, Maria Argos, +15 authors, Habibul Ahsan.
Breast Cancer Res Treat, 2017 May 16; 164(3). PMID: 28503721    Free PMC article.
Prognostic Significance of Focal Adhesion Kinase in Node-Negative Breast Cancer.
Katrin Almstedt, Isabel Sicking, +5 authors, Marcus Schmidt.
Breast Care (Basel), 2017 Dec 14; 12(5). PMID: 29234254    Free PMC article.
PTHrP, A Biomarker for CNS Metastasis in Triple-Negative Breast Cancer and Selection for Adjuvant Chemotherapy in Node-Negative Disease.
Gloria Assaker, Anne Camirand, +7 authors, Siham Sabri.
JNCI Cancer Spectr, 2020 Apr 17; 4(1). PMID: 32296756    Free PMC article.
A Comparison Between the Online Prediction Models CancerMath and PREDICT as Prognostic Tools in Thai Breast Cancer Patients.
Nuanphan Polchai, Doonyapat Sa-Nguanraksa, +3 authors, Pornchai O-Charoenrat.
Cancer Manag Res, 2020 Aug 06; 12. PMID: 32753968    Free PMC article.